...
首页> 外文期刊>Frontiers in Nutrition >Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models
【24h】

Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models

机译:癌症恶化的营养干预:实验模型的证据和观点

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss and is associated with poor clinical outcome, decreased survival and negatively influences cancer therapy. No curative treatments are available for cancer cachexia, but nutritional intervention is recommended as a cornerstone of multimodal therapy. Optimal nutritional care is pivotal in the treatment of cancer cachexia, and the effects of nutrients may extend beyond provision of adequate energy uptake, targeting different mechanisms or metabolic pathways that are affected or deregulated by cachexia. The evidence to support this notion derived from nutritional intervention studies in experimental models of cancer cachexia is systematically discussed in this review. Moreover, experimental variables and readout parameters to determine skeletal muscle wasting and cachexia are methodologically evaluated to allow critical comparison of similar studies. Single- and multinutrient intervention studies including qualitative modulation of dietary protein, dietary fat, and supplementation with specific nutrients, such as carnitine and creatine, were reviewed for their efficacy to counteract muscle mass loss and its underlying mechanisms in experimental cancer cachexia. Numerous studies showed favorable effects on impaired protein turnover and related metabolic abnormalities of nutritional supplementation in parallel with a beneficial impact on cancer-induced muscle wasting. The combination of high quality nutrients in a multinutrient approach appears specifically promising, preferentially as a multimodal intervention, although more studies investigating the optimal quantity and combination of nutrients are needed. During the review process, a wide variation in timing, duration, dosing and route of supplementation, as well as a wide variation in animal models were observed. Better standardization in dietary design, and the development of experimental models that better recapitulate the etiology of human cachexia, will further facilitate successful translation of experimentally-based multinutrient, multimodal interventions into clinical practice.
机译:癌症恶化是一种复杂的代谢综合征,其特征是由非自愿的骨骼肌损失,与临床结果不良有关,生存率下降和对癌症治疗的负面影响。癌症恶病症没有治疗方法,但建议营养干预作为多式联运疗法的基石。在治疗癌症恶病症的治疗中赋予最佳营养护理,并且营养物质的影响可以超越提供足够的能量摄取,靶向受影响或通过恶病毒造成的不同机制或代谢途径。在本次审查中,系统地讨论了支持患有癌症恶化的实验模型中营养干预研究的证据。此外,实验变量和读出参数以确定骨骼肌丢失和恶毒症的方法是在方法上评估的,以允许与类似研究的关键比较。包括定性调节膳食蛋白,膳食脂肪和用特定营养素的定性调节的单一和多胎的干预研究,例如肉碱和肌酸,以抵消肌肉质量损失及其在实验性癌症恶病症中的潜在机制。许多研究表明对蛋白质周转受损和相关的营养补充的相关代谢异常平行对癌症诱导的肌肉浪费的有益影响有利影响。高质量营养素中的组合在多胎面方法中似乎特别承诺,优先考虑到多模式干预,尽管需要更多的研究来调查营养素的最佳数量和组合。在审查过程中,观察到时间,持续时间,剂量和补充途径以及动物模型的广泛变化。更好的饮食设计标准化,以及更好地概念人类恶毒症的病因的实验模型的发展将进一步促进基于实验的多模式的多式联及的临床实践的成功翻译。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号